Overview

Full Product Details

Author:   Alan B. Hollingsworth
Publisher:   McFarland & Co Inc
Imprint:   McFarland & Co Inc
Dimensions:   Width: 17.80cm , Height: 1.30cm , Length: 25.40cm
Weight:   0.458kg
ISBN:  

9781476666105

ISBN 10:   1476666105
Pages:   260
Publication Date:   22 August 2016
Recommended Age:   From 18 years
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Available To Order  
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Table of Contents Acknowledgments Preface 1. Last Word vs. Final Word 2. Early Diagnosis May Be the Key, but It’s Not a Lock 3. Biology Can Trump, but Size Matters 4. Prostate Is Not Breast, So Give It a Rest 5. The Four Horsemen That Inflate the Power of Mammography 6. The Four Horsemen Are Throttled by Clinical Trials, but O Canada! 7. The Mammography Civil War (1993–1997) 8. The Number Games 9. The (Over)Selling of Mammography 10. The Evidence for ­Evidence-Based Medicine (or, How to Raise the Bar of Bias: An Editorial) 11. Blame It on Canada (and Something’s Rotten in Denmark, Too) 12. Overdiagnosis: Embracing Your Inner Malignancy 13. Overdiagnosis Part 2: A Way Out of the Wet Paper Bag 14. The Task Force Opens Fire 15. The Zombies Among Us 16. Circumstantial ­Evidence-Based Medicine 17. The Social Tsunami of ­Anti-Screening 18. The 2015 ACS Peace Accord—Science or Societal Pressure? 19. A Journey to the Pathology Lab to View the ­By-Products of Screening 20. Risk-Based Screening—It Feels So Right, but Wait… 21. The Greatest Story Never Told 22. The Myth of Mammography 23. Do These Genes Make Me Look Dense? 24. The Emperor of All Modalities 25. The Bright Side of the Dark Side of the Force 26. The Crystal Ball Is Fair to Partly Cloudy Chapter Notes Bibliography Index

Reviews

detailed, clearly written chapters...the author...uses his expertise and current findings to convince readers that screening is still worth it. There are an abundance of 'less-is-more' resources available on this subject; however, Hollingsworth's confident, accessible argument against such a philosophy provides a welcome look at another option --<i>Library Journal</i>; What a prodigious accomplishment! My congratulations to Dr. Hollingsworth! --Stephen Feig, M.D.

What a prodigious accomplishment! My congratulations to Dr. Hollingsworth! -- Stephen Feig, M.D. Stephen Feig, M.D.

Author Information

Alan B. Hollingsworth, M.D., serves as medical director of Mercy Breast Center, a screening and diagnostic facility at Mercy Hospital, Oklahoma City. He received his MD with Distinction from the University of Oklahoma College of Medicine in 1975 where he was elected First vice-president of Alpha Omega Alpha Honor Medical Society. He completed a residency in general surgery at the University of Oklahoma that included a one-year fellowship in surgical pathology at UCLA. He limited his practice to breast cancer surgery in the 1980s and was the founding medical director of Oklahoma’s first multidisciplinary breast clinic at his alma mater where he was also named as the first holder of the G. Rainey Williams Chair in Surgical Breast Oncology. He was one of the first physicians in the country to begin a formal risk assessment program in 1993, and today his practice is limited to risk assessment, genetic testing, and multimodality screening for high-risk patients.

Tab Content 6

Author Website:  

Countries Available

All regions